• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019年美国和加拿大病理学会会议上美国细胞病理学会配套会议论文集 第1部分:迈向浆液性液体细胞病理学报告国际体系

Proceedings of the American Society of Cytopathology Companion Session at the 2019 United States and Canadian Academy of Pathology Meeting Part 1: towards an International System for Reporting Serous Fluid Cytopathology.

作者信息

Crothers Barbara A, Chandra Ashish

机构信息

Joint Pathology Center, Silver Spring, Maryland.

Guy's & St. Thomas' National Health Services Foundation Trust, Department of Cellular Pathology, St. Thomas' Hospital, London, United Kingdom.

出版信息

J Am Soc Cytopathol. 2019 Nov-Dec;8(6):362-368. doi: 10.1016/j.jasc.2019.08.006. Epub 2019 Sep 28.

DOI:10.1016/j.jasc.2019.08.006
PMID:31672335
Abstract

INTRODUCTION

The International System for the Reporting of Serous Fluid Cytopathology was initiated to provide a common language for cytopathology reports on body fluids.

MATERIALS AND METHODS

The International Academy of Cytology and the American Society of Cytopathology collaborated to provide evidence-based and expert-driven terminology for reporting serous fluids. Lead editors were selected and expert authors invited to form working groups for the diagnostic categories and special sections.

RESULTS

Preliminary results of the collaboration include the 6 diagnostic terminology categories: non-diagnostic, negative for malignancy, atypia of undetermined significance, suspicious for malignancy, malignant-primary, and malignant-metastatic. Four special sections on ancillary testing, peritoneal washings, cytotechnical aspects, and quality assurance will appear in the final text. Initial results of an international survey indicate strong support for a uniform terminology for reporting serous fluids.

CONCLUSIONS

This article outlines the initial findings of the collaboration as presented to the United States and Canadian Academy of Pathology at the 2019 annual meeting at the National Harbor, MD.

摘要

引言

发起国际浆液性液体细胞病理学报告系统是为了为体液的细胞病理学报告提供一种通用语言。

材料与方法

国际细胞学会和美国细胞病理学会合作,为浆液性液体报告提供基于证据且由专家主导的术语。挑选了主编并邀请专家作者组成诊断类别和特殊部分的工作组。

结果

合作的初步结果包括6个诊断术语类别:无法诊断、恶性阴性、意义未明的非典型性、恶性可疑、原发性恶性和转移性恶性。关于辅助检测、腹腔灌洗、细胞技术方面和质量保证的4个特殊部分将出现在最终文本中。一项国际调查的初步结果表明,对浆液性液体报告采用统一术语有强烈支持。

结论

本文概述了在马里兰州国家港举行的2019年美国和加拿大病理学会年会上提交的合作初步结果。

相似文献

1
Proceedings of the American Society of Cytopathology Companion Session at the 2019 United States and Canadian Academy of Pathology Meeting Part 1: towards an International System for Reporting Serous Fluid Cytopathology.2019年美国和加拿大病理学会会议上美国细胞病理学会配套会议论文集 第1部分:迈向浆液性液体细胞病理学报告国际体系
J Am Soc Cytopathol. 2019 Nov-Dec;8(6):362-368. doi: 10.1016/j.jasc.2019.08.006. Epub 2019 Sep 28.
2
Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology Annual meeting, part 2: effusion cytology with focus on theranostics and diagnosis of malignant mesothelioma.2019年美国和加拿大病理学会年会上美国细胞病理学会配套会议论文集,第2部分:积液细胞学,重点关注恶性间皮瘤的治疗诊断学与诊断
J Am Soc Cytopathol. 2019 Nov-Dec;8(6):352-361. doi: 10.1016/j.jasc.2019.07.005. Epub 2019 Aug 8.
3
Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.国际浆膜腔液细胞病理学报告系统在胸腔积液常规报告中的应用及恶性肿瘤风险评估。
Diagn Cytopathol. 2021 Oct;49(10):1089-1098. doi: 10.1002/dc.24837. Epub 2021 Jul 21.
4
The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management.国际浆膜腔液细胞病理学报告系统-诊断类别和临床管理。
J Am Soc Cytopathol. 2020 Nov-Dec;9(6):469-477. doi: 10.1016/j.jasc.2020.05.015. Epub 2020 Jun 9.
5
The international system for reporting serous fluid cytopathology: The initial project survey.浆液性液体细胞病理学报告国际系统:初步项目调查
Cytopathology. 2023 May;34(3):191-197. doi: 10.1111/cyt.13218. Epub 2023 Mar 1.
6
Application of the newly published International System for Reporting Serous Fluid Cytopathology in atypical and suspicious diagnosis: a four-year retrospective analysis.新发布的国际浆膜腔液细胞病理学报告系统在非典型和可疑诊断中的应用:一项四年回顾性分析。
J Am Soc Cytopathol. 2024 Jul-Aug;13(4):303-308. doi: 10.1016/j.jasc.2024.03.001. Epub 2024 Mar 19.
7
A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.回顾性分析新提出的国际浆膜腔液细胞病理学报告系统在浆膜腔积液标本中的应用:机构经验。
Acta Cytol. 2023;67(1):70-79. doi: 10.1159/000527398. Epub 2022 Dec 7.
8
Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.国际浆膜液细胞病理学报告系统(ISRSFC)在心包积液细胞学报告中的应用。
Acta Cytol. 2020;64(5):477-485. doi: 10.1159/000507311. Epub 2020 May 18.
9
Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion: A retrospective study.国际浆膜腔液细胞病理报告系统(ISRSFC)在浆膜腔积液报告中的应用:一项回顾性研究。
Medicine (Baltimore). 2023 Oct 27;102(43):e35707. doi: 10.1097/MD.0000000000035707.
10
Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.使用国际浆膜腔液细胞病理学报告系统对浆膜腔积液进行分类,并评估诊断准确性的恶性肿瘤风险。
Cytopathology. 2022 Mar;33(2):176-184. doi: 10.1111/cyt.13089. Epub 2021 Dec 28.

引用本文的文献

1
Deciphering Serous Effusions Using the New International System for Reporting Serous Fluid Cytopathology.使用新的国际浆液性液体细胞病理学报告系统解读浆液性积液
Cureus. 2024 May 10;16(5):e60042. doi: 10.7759/cureus.60042. eCollection 2024 May.
2
Optimal Volume Assessment for Serous Fluid Cytology.浆液性液体细胞学的最佳体积评估
Biomedicines. 2024 Apr 18;12(4):899. doi: 10.3390/biomedicines12040899.
3
The International System for Reporting Serous Fluid Cytopathology: An Institutional Experience on its Implication and Assessment of Risk of Malignancy in Effusion Cytology.
国际浆液性液体细胞病理学报告系统:关于其在积液细胞学中恶性风险评估及意义的机构经验
J Cytol. 2023 Oct-Dec;40(4):159-164. doi: 10.4103/joc.joc_111_22. Epub 2023 Oct 16.
4
A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center.基于新提出的国际浆膜腔液细胞学报告系统的浆膜腔积液回顾性分析:肿瘤中心 3633 例病例报告。
Diagn Pathol. 2022 Jul 2;17(1):56. doi: 10.1186/s13000-022-01241-4.
5
Combination of Biochemical and Cytological Findings for Better Diagnosis in Pleural Effusions.联合生化和细胞学检查结果以提高胸腔积液的诊断水平。
Adv Exp Med Biol. 2022;1374:51-62. doi: 10.1007/5584_2021_703.
6
Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.国际浆液性液体细胞病理学报告系统在细胞组织学相关性及恶性风险评估中的应用
Diagnostics (Basel). 2021 Nov 28;11(12):2223. doi: 10.3390/diagnostics11122223.
7
Cytohistological Correlation in Pleural Effusions Based on the International System for Reporting Serous Fluid Cytopathology.基于国际浆液性液体细胞病理学报告系统的胸腔积液细胞组织学相关性
Diagnostics (Basel). 2021 Jun 20;11(6):1126. doi: 10.3390/diagnostics11061126.